INTEGRATED BIOPHARMA INC (ticker: INBP) is an OTC-listed pharma company. DredgeCap's structured extraction of INBP's SEC filings surfaces 23 active risk signals, including 19 late-filing signals, 2 delisting/deregistration signals, and 2 auditor-change signals. INBP reported $10.30M in revenue and -$1.48M for the period ending 2018-09-30, with operating cash flow of $2.44M. Cash and equivalents stood at $5.83M (up 96.8% year-over-year). Total assets of $26.67M exceed total liabilities of $7.69M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
INBP Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for INTEGRATED BIOPHARMA INC (INBP) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.